home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Protein Clumps Acquitted In Huntington's Investigation

  October, 26 2004 8:37
your information resource in human molecular genetics
An innovative microscope study described in the 14 October 2004 issue of Nature (Vol. 431, No. 7010, see pp. 805-810, and News & Views) has answered a long-standing question about the fatal neurodegenerative disorder Huntington's disease. Researchers have discovered that the tiny clumps of abnormal protein found in diseased nerve cells actually help to boost the cells' chances of survival.

Steven Finkbeiner and colleagues dosed cultured brain cells with the abnormal version of the protein huntingtin, which causes the disease. They then monitored them using an automated microscope that returns time and again to the same individual cell, even if it dies.

Cells were more likely to die if given a large dose of mutant protein. But this risk of death was reduced if the protein formed clumps called inclusion bodies. So it seems that these clumps protect against the protein's toxic effects by reducing the amount of spread throughout the cell - some experts had previously suggested that it is the clumps themselves that do the damage.

This approach potentially offers a way to work out whether the protein clumps found in other diseases such as Alzheimer's are harmful, beneficial or merely incidental, says Harry T. Orr in an accompanying News and Views article.


Steven Finkbeiner (University of California, San Francisco, CA, USA)
Tel: +1 415 695 3868, E-mail: sfinkbeiner@gladstone.ucsf.edu

Harry T. Orr (University of Minnesota, Minneapolis, MN, USA)
Tel: +1 612 625 3647, E-mail: harry@lenti.med.umn.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.